Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ...
Leerink Partners analyst Roanna Ruiz reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) on January 13 and set a price target ...
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective raised by Leerink Partners from $18.00 to $20.00 in ...
Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Vir Biotechnology (VIR – Research Report) yesterday and set a ...
Vir Biotechnology Inc (VIR) stock saw a decline, ending the day at $12.1 which represents a decrease of $-0.38 or -3.04% from the prior close of $12.48. The stock opened at $12.69 and touched a low of ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
With new legislation and noteworthy policies on sci-tech and innovation expected this year, businesses are hoping the right ...
China Medical University and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel ...
A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...
EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Thursday reported a loss of $10.7 million in its third quarter. The East Princeton, New Jersey-based company said it had a ...